Exhibit 99.1
|
|
|
|
|
|
|
3560 Bassett Street, Santa Clara CA 95054
|
|
|
|
Jeff Andreson
|
|
Claire McAdams
|
Chief Financial Officer
|
|
Headgate Partners LLC
|
(408) 986-9888
|
|
(530) 274-0551
|
INTEVAC ANNOUNCES FOURTH QUARTER AND
FULL YEAR 2007 FINANCIAL RESULTS
Exceeding Expectations in a Difficult Business Environment
Santa Clara, Calif.February 5, 2008Intevac, Inc. (Nasdaq: IVAC) today reported financial
results for the fourth quarter and year ended December 31, 2007.
Net loss for the quarter was $2.4 million, or $0.11 per diluted share, on 21.6 million
weighted-average shares outstanding. The net loss included $1.7 million of stock-based compensation
expense, equivalent to $0.05 per diluted share. Fourth quarter earnings include a $1.5 million
one-time gain on the sale of a real estate investment, equivalent to $0.05 per diluted share. For
the fourth quarter of 2006, net income was $21.3 million, or $0.97 per diluted share, on 22.1
million weighted average shares outstanding, which included $1.3 million of stock-based
compensation expense, equivalent to $0.05 per diluted share.
Revenues for the quarter were $16.8 million, including $10.8 million of Equipment revenues and
record Imaging revenues of $6.0 million. As no 200 Lean
®
systems were shipped in the
quarter, equipment revenues consisted of disk lubrication systems, equipment upgrades, spares,
consumables and service. Imaging revenues consisted of $4.1 million of research and development
contracts and a record $1.9 million of product sales. In the fourth quarter of 2006, revenues were
$95.9 million, including $92.8 million of Equipment revenues and $3.1 million of Imaging revenues,
which included $331,000 of product sales.
Equipment and Imaging gross margins for the fourth quarter of 2007 rose to 46.7% and 46.7%,
respectively, from 40.9% and 37.9% for the fourth quarter of 2006. Equipment margins improved
because Equipment revenues were driven primarily by technology upgrades and spares business.
Imaging margins improved as a result of securing higher-margin development contracts and an
increased percentage of revenue derived from higher-margin product shipments. Consolidated gross
margins improved to 46.7%, from 40.8% in the fourth quarter of 2006.
Operating expenses for the quarter totaled $14.9 million, or 89% of revenues, versus $16.9 million,
or 17.6% of revenues, in the fourth quarter of 2006 and $16.5 million, or 32.6% of revenues, in the
third quarter of 2007. For the third sequential quarter, operating expenses have declined. Total
operating expenses decreased versus the fourth quarter of 2006 primarily because of reductions in
R&D and general and administrative expenses.
Net income for the full year 2007 was $27.3 million, or $1.23 per diluted share, on 22.2 million
weighted-average shares outstanding. Net income included $6.2 million of stock-based compensation
expense, equivalent to $0.22 per diluted share, and a $1.5 million one-time gain on the sale of an
investment, equivalent to $0.05 per diluted share. For the full year 2006, net income was $46.7
million, or $2.13 per diluted share, on 21.9 million weighted average shares outstanding, which
included $3.4 million of stock-based compensation expense, equivalent to $0.13 per diluted share.
Revenues for the full year were $215.8 million, including $196.7 million of Equipment revenues and
$19.1 million of Imaging revenues. Equipment revenues consisted of twenty-nine 200 Lean
®
systems as well as disk lubrication systems, equipment upgrades, spares, consumables and service.
Imaging revenues consisted of $13.9 million of research and development contracts and $5.2 million
of product sales. For the full year 2006, revenues were $259.9 million, including $248.5 million of
Equipment revenues and $11.4 million of Imaging revenues, which included $1.7 million of product
sales.
Equipment and Imaging gross margins for the year increased to 44.7% and 42.6%, respectively, from
39.1% and 33.3% in 2006. Equipment margins improved primarily due to record high sales of
technology upgrades and spares as well as reduced manufacturing costs. Imaging margins increased
primarily as the result of securing higher-margin development contracts, higher factory utilization
and an increased percentage of revenue derived from higher-margin product shipments. Consolidated
gross margins improved to 44.5%, from 38.8% in 2006.
Operating expenses for the year totaled $68.6 million, or 31.8% of revenues, versus $53.0 million,
or 20.4% of revenues, in 2006. Operating expenses grew primarily as the result of increased
spending on development of new Equipment products, increased business development expense, legal
expenses associated with patent litigation and higher stock-based compensation expense.
Order backlog totaled $34.2 million on December 31, 2007, compared to $31.2 million on September
29, 2007 and $125.0 million on December 31, 2006. Backlog at year end includes two 200
Lean
®
systems, compared to one on September 29, 2007 and twenty-four on December 31,
2006.
We delivered stronger-than-expected results for the fourth quarter, as we responded to a
challenging market environment by reducing our cost structure without slowing down the development
of our future growth products, commented Kevin Fairbairn, president and chief executive officer of
Intevac. Fourth quarter revenues declined 83% from last years record-setting fourth quarter, yet
we delivered higher gross margins, lower operating expenses and another profitable quarter for our
Imaging business. We also completed the acquisition of Creative Display Systems, which we expect
to be accretive to earnings by the end of 2008, to expand our served markets and contribute to the
competitiveness of our future night vision products.
Conference Call Information
The Company will discuss its financial results and outlook in a conference call today at 1:30 p.m.
PT (4:30 p.m. ET). To participate in the teleconference, please call toll-free (800) 291-8929 prior
to the start time. For international callers, the dial-in number is (706) 634-0478. You may also
listen live via the Internet at the Companys website, www.Intevac.com, under the Investors link,
or at www.earnings.com. For those unable to attend, these web sites will host an archive of the
call. Additionally, a telephone replay of the call will be available for 48 hours beginning today
at 7:30 p.m. ET. You may access the playback by calling (800) 642-1687, or for international
callers (706) 645-9291, and providing conference ID 30259361.
About Intevac
Intevac was founded in 1991 and has two businesses: Equipment and Imaging Instrumentation.
Equipment Business: Intevac is a leader in the design, manufacture and marketing of
high-productivity lean manufacturing systems and has been producing Lean Thinking platforms
since 1994. We are the leading supplier of magnetic media sputtering equipment to the hard disk
drive industry and offer leading-edge, high-productivity etch systems to the semiconductor
industry.
Imaging Instrumentation Business: Intevac is a leader in the development of compact,
cost-effective, high-sensitivity digital-optical products for the capture and display of low-light
images and the optical analysis of materials. We provide sensors, cameras and systems for
commercial applications in the inspection, medical, scientific and security industries, and for
government applications such as night vision and long-range target identification.
For more
information call 408-986-9888, or visit the Companys website at
www.intevac.com
.
200 Lean
®
is a registered trademark of Intevac, Inc.
Safe Harbor Statement
This press release includes statements that constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 (the Reform Act). Intevac claims
the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms may, believes, projects,
expects, or anticipates, and do not reflect historical facts. Specific forward-looking
statements contained in this press release include, but are not limited to, the progress and
expected growth relating to new product development, expected growth of its Imaging Instrumentation
business and success of the CDS acquisition and management of the Companys operating expenses. The
forward-looking statements contained herein involve risks and uncertainties that could cause actual
results to differ materially from the Companys expectations. These risks include, but are not
limited to: failure to increase Imaging Instrumentation revenues, manage operating expenses or
introduce new products, each of which could have a material impact on our business, our financial
results, and the Companys stock price. These risks and other factors are detailed in the Companys
regular filings with the U.S. Securities and Exchange Commission.
[Financial tables on following pages]
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 months ended
|
|
|
12 months ended
|
|
|
|
Dec 31,
|
|
|
Dec. 31,
|
|
|
Dec 31,
|
|
|
Dec. 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
|
|
|
Net revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equipment
|
|
$
|
10,801
|
|
|
$
|
92,819
|
|
|
$
|
196,686
|
|
|
$
|
248,482
|
|
Imaging
|
|
|
5,950
|
|
|
|
3,065
|
|
|
|
19,148
|
|
|
|
11,393
|
|
|
|
|
|
|
Total net revenues
|
|
$
|
16,751
|
|
|
$
|
95,884
|
|
|
$
|
215,834
|
|
|
$
|
259,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
7,819
|
|
|
|
39,111
|
|
|
|
96,043
|
|
|
|
100,959
|
|
Gross margin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equipment
|
|
|
46.7
|
%
|
|
|
40.9
|
%
|
|
|
44.7
|
%
|
|
|
39.1
|
%
|
Imaging
|
|
|
46.7
|
%
|
|
|
37.9
|
%
|
|
|
42.6
|
%
|
|
|
33.3
|
%
|
|
|
|
|
|
Consolidated
|
|
|
46.7
|
%
|
|
|
40.8
|
%
|
|
|
44.5
|
%
|
|
|
38.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
8,860
|
|
|
|
9,614
|
|
|
|
40,137
|
|
|
|
30,036
|
|
Selling, general and administrative
|
|
|
6,056
|
|
|
|
7,241
|
|
|
|
28,470
|
|
|
|
22,924
|
|
|
|
|
|
|
Total operating expenses
|
|
|
14,916
|
|
|
|
16,855
|
|
|
|
68,607
|
|
|
|
52,960
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equipment
|
|
|
(6,405
|
)
|
|
|
22,936
|
|
|
|
32,903
|
|
|
|
52,223
|
|
Imaging
|
|
|
161
|
|
|
|
(1,125
|
)
|
|
|
(2,919
|
)
|
|
|
(4,826
|
)
|
Corporate
|
|
|
(853
|
)
|
|
|
445
|
|
|
|
(2,548
|
)
|
|
|
602
|
|
|
|
|
|
|
Total operating income (loss)
|
|
|
(7,097
|
)
|
|
|
22,256
|
|
|
|
27,436
|
|
|
|
47,999
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
|
|
|
3,487
|
|
|
|
1,338
|
|
|
|
8,142
|
|
|
|
3,778
|
|
|
|
|
|
|
Income (loss) before provision for
income taxes
|
|
|
(3,610
|
)
|
|
|
23,594
|
|
|
|
35,578
|
|
|
|
51,777
|
|
Provision for income taxes
|
|
|
(1,194
|
)
|
|
|
2,253
|
|
|
|
8,233
|
|
|
|
5,079
|
|
|
|
|
|
|
Net income (loss)
|
|
|
($2,416
|
)
|
|
$
|
21,341
|
|
|
$
|
27,345
|
|
|
$
|
46,698
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
($0.11
|
)
|
|
$
|
1.01
|
|
|
$
|
1.28
|
|
|
$
|
2.22
|
|
Diluted
|
|
|
($0.11
|
)
|
|
$
|
0.97
|
|
|
$
|
1.23
|
|
|
$
|
2.13
|
|
Weighted average common shares
outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
21,580
|
|
|
|
21,161
|
|
|
|
21,447
|
|
|
|
21,016
|
|
Diluted
|
|
|
21,580
|
|
|
|
22,083
|
|
|
|
22,150
|
|
|
|
21,937
|
|
-more-
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
Dec. 31
|
|
|
Dec. 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and short term investments
|
|
$
|
138,658
|
|
|
$
|
95,035
|
|
Accounts receivable, net
|
|
|
14,142
|
|
|
|
39,927
|
|
Inventories
|
|
|
22,133
|
|
|
|
37,942
|
|
Deferred tax assets
|
|
|
5,744
|
|
|
|
3,269
|
|
Prepaid expenses and other current assets
|
|
|
1,866
|
|
|
|
2,506
|
|
|
|
|
Total current assets
|
|
|
182,543
|
|
|
|
178,679
|
|
|
|
|
|
|
|
|
|
|
Long term investments
|
|
|
2,009
|
|
|
|
8,000
|
|
Property, plant and equipment, net
|
|
|
15,402
|
|
|
|
13,546
|
|
Investment in 601 California Avenue LLC
|
|
|
|
|
|
|
2,431
|
|
Deferred tax assets
|
|
|
1,601
|
|
|
|
1,312
|
|
Goodwill
|
|
|
7,905
|
|
|
|
|
|
Other long-term assets
|
|
|
3,653
|
|
|
|
2,035
|
|
|
|
|
Total assets
|
|
$
|
213,113
|
|
|
$
|
206,003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
Notes payable
|
|
$
|
1,992
|
|
|
|
|
|
Accounts payable
|
|
|
7,678
|
|
|
$
|
15,994
|
|
Accrued payroll and related liabilities
|
|
|
8,610
|
|
|
|
11,769
|
|
Other accrued liabilities
|
|
|
3,236
|
|
|
|
6,612
|
|
Customer advances
|
|
|
4,340
|
|
|
|
26,243
|
|
|
|
|
Total current liabilities
|
|
|
25,856
|
|
|
|
60,618
|
|
|
|
|
|
|
|
|
|
|
Other long-term liabilities
|
|
|
2,176
|
|
|
|
1,075
|
|
Shareholders equity
|
|
|
|
|
|
|
|
|
Common stock (a) ($0.001 par value)
|
|
|
22
|
|
|
|
99,468
|
|
Paid in capital (a)
|
|
|
119,974
|
|
|
|
7,319
|
|
Accumulated other comprehensive income
|
|
|
571
|
|
|
|
354
|
|
Retained earnings
|
|
|
64,514
|
|
|
|
37,169
|
|
|
|
|
Total shareholders equity
|
|
|
185,081
|
|
|
|
144,310
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
213,113
|
|
|
$
|
206,003
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
Reclassification related to Companys Reincorporation in the State of Delaware.
|
-more-
SUPPLEMENTAL INFORMATION REGARDING IMPACT OF THE ADOPTION OF SFAS 123(R)
The effect of recording stock-based compensation for the three- and twelve-month periods ended
December 31, 2007 and December 31, 2006 were as follows (in Thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
|
|
|
Dec. 31,
|
|
|
Dec. 31
|
|
|
Dec. 31,
|
|
|
Dec. 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
(Unaudited)
|
|
|
|
|
|
Stock-based compensation by type of award:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options
|
|
$
|
1,525
|
|
|
$
|
1,117
|
|
|
$
|
5,517
|
|
|
$
|
2,803
|
|
Employee Stock Purchase Plan
|
|
|
246
|
|
|
|
190
|
|
|
|
864
|
|
|
|
622
|
|
Amounts capitalized as inventory
|
|
|
(74
|
)
|
|
|
(8
|
)
|
|
|
(179
|
)
|
|
|
(69
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation
|
|
|
1,697
|
|
|
|
1,299
|
|
|
|
6,202
|
|
|
|
3,356
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax effect on stock-based compensation
|
|
|
582
|
|
|
|
186
|
|
|
|
1,426
|
|
|
|
403
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net effect on net income
|
|
$
|
1,115
|
|
|
$
|
1,113
|
|
|
$
|
4,776
|
|
|
$
|
2,953
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect on earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.05
|
|
|
$
|
0.05
|
|
|
$
|
0.22
|
|
|
$
|
0.14
|
|
Diluted
|
|
$
|
0.05
|
|
|
$
|
0.05
|
|
|
$
|
0.22
|
|
|
$
|
0.13
|
|
Approximately $179,000 and $69,000 of stock-based compensation was capitalized to inventory during
the years ending December 31, 2007 and December 31, 2006, respectively.